Proton Radiation for the Treatment of Pediatric Bone and Non-Rhabdomyosarcoma Soft Tissue Sarcomas

Inclusion Criteria: * Biopsy proven Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) or bone sarcoma * Less than or equal to 30 years of age * Patients must have been treated with a standardly accepted chemotherapy regimen if chemotherapy is indicated * Patients must be willing to receive follow-up care for a minimum of five years after treatment at MGH and annual visits unless it is too difficult to return to MGH for follow-up care. In that event, the patient or guardian must be willing to have their outside medical information released in order to track the results of treatment * They or their legal guardian must give their informed consent * Timing of radiation may be according to concurrent protocol Exclusion Criteria: * Co-morbidities that would make the use of radiation too toxic to deliver safely, such as serious local injury of collagen vascular disease * Patients who are pregnant * Previous treatment with radiation therapy * Concurrent adriamycin or gemcitabine chemotherapy is planned, unless on a concurrent protocol